Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Atherosclerosis Reports
Published in: Current Atherosclerosis Reports 3/2010

01-05-2010

The Evolving Definition of Systemic Arterial Hypertension

Authors: C. Venkata S. Ram, Thomas D. Giles

Published in: Current Atherosclerosis Reports | Issue 3/2010

Login to get access

Abstract

Systemic hypertension is an important risk factor for premature cardiovascular disease. Hypertension also contributes to excessive morbidity and mortality. Whereas excellent therapeutic options are available to treat hypertension, there is an unsettled issue about the very definition of hypertension. At what level of blood pressure should we treat hypertension? Does the definition of hypertension change in the presence of co-morbid conditions? This article covers in detail the evolving concepts in the diagnosis and management of hypertension.
Literature
1.
The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1984, 144:1045–1057.
2.
Chobanian AV, Bakris GL, Black HR, et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206–1252.CrossRefPubMed
3.
Franco OH, Peeters A, Bonneux L, de Laet C: Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension 2005, 46:280–286.CrossRefPubMed
4.
Lewington S, Clarke R, Qizilbash N, et al., for the Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903–1913.CrossRefPubMed
5.
Giles TD, Berk BC, Black HR et al.; on behalf of the Hypertension Working Group: Expanding the definition and classification of hypertension. J Clin Hypertens 2005, 7:505–512.CrossRef
6.
Elias PK, Elias MF, Robbins MA, Budge MM: Blood pressure-related cognitive decline: does age make a difference? Hypertension 2004, 44:612–613.CrossRef
7.
Qureshi AI, Suri MF, Kirmani JF, et al.: Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005, 36:1859–1863.CrossRefPubMed
8.
Greenlund KJ, Croft JB, Mensah GA: Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999–2000. Arch Intern Med 2004, 164:2113–2118.CrossRefPubMed
9.
Chrysohoou C, Pitsavos C, Panagiotakos DB, et al.: Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA study. Am J Hypertens 2004, 17:568–573.CrossRefPubMed
10.
Law MR, Moms JK, Wald NJ: Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomized trials in the context of expectations from prospective epidemiological studies. BMJ 2009, 338:1245–1259.
11.
Kostis JB, Messerli F, Giles TD: Hypertension: definitions and guidelines. J Clin Hypertens 2005, 7:538–539.CrossRef
12.
Kannel WB, McGee D, Gordon T: A general cardiovascular risk profile: the Framingham study. Am J Cardiol 1976, 38:46–51.CrossRefPubMed
Metadata
Title
The Evolving Definition of Systemic Arterial Hypertension
Authors
C. Venkata S. Ram
Thomas D. Giles
Publication date
01-05-2010
Publisher
Current Science Inc.
Published in
Current Atherosclerosis Reports / Issue 3/2010
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-010-0107-6

Other articles of this Issue 3/2010

Current Atherosclerosis Reports 3/2010 Go to the issue

ReviewPaper

Lipidomics as a Tool for the Study of Lipoprotein Metabolism

ReviewPaper

Genetic Variants of the Renin Angiotensin System: Effects on Atherosclerosis in Experimental Models and Humans

ReviewPaper

New Technologies Personalize Diagnostics and Therapeutics

ReviewPaper

Genetics of Atherothrombosis and Thrombophilia

ReviewPaper

Genomics of Premature Atherosclerotic Vascular Disease

ReviewPaper

Proteomic and Metabolomic Profiles in Atherothrombotic Vascular Disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits